The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study

INTRODUCTION: We designed OP3-4 (YCEIEFCYLIR), a cyclic peptide, to mimic the soluble osteoprotegerin (OPG), and was proven to bind to RANKL (receptor activator of NF-κB ligand), thereby inhibiting osteoclastogenesis. We recently found that another RANKL binding peptide, W9, could accelerate bone fo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arthritis Res Ther
Autors principals: Kato, Genki, Shimizu, Yasuhiro, Arai, Yuki, Suzuki, Natsuki, Sugamori, Yasutaka, Maeda, Miki, Takahashi, Mariko, Tamura, Yukihiko, Wakabayashi, Noriyuki, Murali, Ramachandran, Ono, Takashi, Ohya, Keiichi, Mise-Omata, Setsuko, Aoki, Kazuhiro
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4570694/
https://ncbi.nlm.nih.gov/pubmed/26373710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-015-0753-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars